S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
Status:
Terminated
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Peripheral stem cell transplantation may allow the doctor to give
higher doses of chemotherapy drugs and kill more tumor cells. It is not yet known which
regimen of chemotherapy followed by peripheral stem cell transplantation is more effective
for breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
plus peripheral stem cell transplantation in treating women who have undergone surgery for
breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI)